The Natural Product Oridonin as an Anticancer Agent: Current Achievements and Problems

被引:3
作者
Hu, Xiangyan [1 ]
Huang, Sisi [1 ,2 ]
Ye, Shiying [1 ]
Jiang, Jinhuan [1 ,3 ]
机构
[1] Univ South China, Hengyang Med Sch, Inst Pharm & Pharmacol, Sch Pharmaceut Sci, Hengyang 421001, Hunan, Peoples R China
[2] Fudan Univ, Pharm Sch, Shanghai Inst Biomed & Pharmaceut Technol, NHC Key Lab Reprod Regulat, Shanghai 200032, Peoples R China
[3] Univ South China, Hengyang Med Sch, Hunan Prov Key Lab Tumor Microenvironm Respons Dru, Hengyang 421001, Hunan, Peoples R China
基金
湖南省自然科学基金;
关键词
Oridonin; anticancer; molecular mechanism; signaling pathway; herbal medicine; apoptosis; EPITHELIAL-MESENCHYMAL TRANSITION; CELL-CYCLE ARREST; INHIBITS MIGRATION; MELANOMA-CELLS; CANCER GROWTH; APOPTOSIS; AUTOPHAGY; PATHWAY; CARCINOMA; INVASION;
D O I
10.2174/1389201024666230821110116
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Oridonin, an active diterpenoid isolated from traditional Chinese herbal medicine, has received a rising attention for its remarkable roles in cancer therapy. In recent years, increasing evidences have revealed that oridonin inhibits the occurrence and development of tumor cells through multiple mechanisms, including induction of apoptosis and autophagy, cell cycle arrest, and inhibition of angiogenesis as well as migration and invasion. In addition, several molecular signal targets have been identified, including ROS, EGFR, NF-kappa B, PI3K/Akt, and MAPK. In this paper, we review considerable knowledge about the molecular mechanisms and signal targets of oridonin, which has been studied in recent years. It is expected that oridonin may be developed as a novel anti-tumor herbal medicine in human cancer treatment.
引用
收藏
页码:655 / 664
页数:10
相关论文
共 88 条
  • [31] Cetuximab enhances oridonin-induced apoptosis through mitochondrial pathway and endoplasmic reticulum stress in laryngeal squamous cell carcinoma cells
    Kang, Ning
    Cao, Shijie
    Jiang, Benke
    Zhang, Qiang
    Donkor, Paul Owusu
    Zhu, Yan
    Qiu, Feng
    Gao, Xiumei
    [J]. TOXICOLOGY IN VITRO, 2020, 67
  • [32] Oridonin enhances antitumor effects of doxorubicin in human osteosarcoma cells
    Kazantseva, Liliya
    Becerra, Jose
    Santos-Ruiz, Leonor
    [J]. PHARMACOLOGICAL REPORTS, 2022, 74 (01) : 248 - 256
  • [33] Oridonin Induces Apoptosis of Laryngeal Carcinoma via Endoplasmic Reticulum Stress
    Kou, Bo
    Yang, Yang
    Bai, Yin-E
    Shi, Yu-Han
    Gao, Rui-Xia
    Yang, Fang-Li
    Zhang, Shao-Qiang
    Liu, Wei
    [J]. CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 8387 - 8396
  • [34] Novel mechanism of inhibition of nuclear factor-κB DNA-binding activity by diterpenoids isolated from Isodon rubescens
    Leung, CH
    Grill, SP
    Lam, W
    Han, QB
    Sun, HD
    Cheng, YC
    [J]. MOLECULAR PHARMACOLOGY, 2005, 68 (02) : 286 - 297
  • [35] Oridonin inhibits migration, invasion, adhesion and TGF-β1-induced epithelial-mesenchymal transition of melanoma cells by inhibiting the activity of PI3K/Akt/GSK-3β signaling pathway
    Li, Chun-Yu
    Wang, Qi
    Shen, Shen
    Wei, Xiao-Lu
    Li, Guo-Xia
    [J]. ONCOLOGY LETTERS, 2018, 15 (01) : 1362 - 1372
  • [36] Inactivation of Ras and changes of mitochondrial membrane potential contribute to oridonin-induced autophagy in A431 cells
    Li, Dan
    Cui, Qiao
    Chen, Shen-geng
    Wu, Li-jun
    Tashiro, Shin-ichi
    Onodera, Satoshi
    Ikejima, Takashi
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2007, 105 (01) : 22 - 33
  • [37] Oridonin-induced A431 cell apoptosis partially through blockage of the Ras/Raf/ERK signal pathway
    Li, Dan
    Wu, Li-jun
    Tashiro, Shin-ichi
    Onodera, Satoshi
    Ikejima, Takashi
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2007, 103 (01) : 56 - 66
  • [38] Oridonin inhibits growth and induces apoptosis of human neurocytoma cells via the Wnt/-catenin pathway
    Liang, Jingyan
    Wang, Weiguang
    Wei, Lifu
    Gao, Shan
    Wang, Yingge
    [J]. ONCOLOGY LETTERS, 2018, 16 (03) : 3333 - 3340
  • [39] Preparation, characterization, and pharmacokinetics of oridonin-loaded liposomes
    Lin, Fei-er
    Zhang, Xin-yan
    Zhang, Yu-ping
    Wang, Jin
    [J]. BIOMEDICAL CHROMATOGRAPHY, 2023, 37 (05)
  • [40] Anti-tumor activity of oridonin on SNU-5 subcutaneous xenograft model via regulation of c-Met pathway
    Liu, Hua
    Qian, Changlin
    Shen, Zhiyong
    [J]. TUMOR BIOLOGY, 2014, 35 (09) : 9139 - 9146